This inventor holds 6 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Remedy Pharmaceuticals, Inc., Biogen Chesapeake LLC. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Thomas W. Macallister: Inventor in Stroke Treatment
Introduction
Thomas W. Macallister is an inventor based in Montross, Virginia. His work includes patent inventions related to treating ischemic stroke and reducing the risk of brain swelling. He is associated with 6 patents.
Latest Patents
Macallister’s listed latest patent is “Methods of Treating Ischemic Stroke at Risk for Cerebral or Cerebellar Edema.” The invention describes using SUR1-TRPM4 channel inhibitors alongside mechanical thrombectomy to treat ischemic stroke patients at risk of cerebral or cerebellar edema.
The methods include embodiments for patients with large hemispheric infarctions and patients whose lesion volumes fall below specified thresholds when measured using MRI diffusion-weighted imaging or CT perfusion. The patent also describes potential treatment for wake-up stroke patients and for patients receiving decompressive therapy.
Career Highlights
Macallister has been associated with Remedy Pharmaceuticals, Inc. and Biogen Chesapeake LLC. His patent work reflects an emphasis on therapeutic approaches for ischemic stroke and its potentially serious complications.
Collaborations
Sven Jacobson is identified as a coworker. The available information does not specify the nature or scope of their collaboration.
Conclusion
Thomas W. Macallister’s patent portfolio includes work on combining drug treatment with mechanical thrombectomy to address ischemic stroke and the risk of brain swelling.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile